Literature DB >> 26251132

Tissue repair in osteoradionecrosis using pentoxifylline and tocopherol--report of three cases.

Joslei Carlos Bohn1, Juliana Lucena Schussel2,3, Roberta Targa Stramandinoli-Zanicotti1, Laurindo Moacir Sassi1.   

Abstract

PURPOSE: Osteoradionecrosis is a complication of head and neck radiotherapy, with a difficult resolution and no well-established treatment. The disease progression can cause important loss on patient's quality of life after cancer treatment. The options for treatment are limited and include clinical monitoring, prescription, or surgical procedures. As an alternative for bone necrosis treatment, a combination of drugs, pentoxifylline and tocopherol, can be used. Studies have shown that this combination significantly reduces chronic radiotherapy damage. The article reports successful treatment with this prescription protocol.
METHODS: We report three cases of patients referred to the Service of Oral and Maxillofacial Surgery at Erasto Gaertner Hospital, in Curitiba, Brazil. They were submitted to radiotherapy for the treatment of malignant head and neck tumors and later developed osteoradionecrosis. They were treated with the combination pentoxifylline and tocopherol.
RESULTS: All patients achieved complete remission in less than 1 year, with complete healing of bone exposure and without clinical symptoms.
CONCLUSIONS: This results show that this combination of drugs is beneficial in cases of bone necrosis induced by radiation, avoiding more aggressive treatments and reducing morbidity.

Entities:  

Keywords:  Osteoradionecrosis; Pentoxifylline; Radiotherapy; Tocopherol

Mesh:

Substances:

Year:  2015        PMID: 26251132     DOI: 10.1007/s10006-015-0522-5

Source DB:  PubMed          Journal:  Oral Maxillofac Surg        ISSN: 1865-1550


  31 in total

1.  Osteoradionecrosis of the mandible: scientific basis for clinical staging.

Authors:  Harry C Schwartz; A Robert Kagan
Journal:  Am J Clin Oncol       Date:  2002-04       Impact factor: 2.339

Review 2.  Cytokines, phagocytes, and pentoxifylline.

Authors:  G L Mandell
Journal:  J Cardiovasc Pharmacol       Date:  1995       Impact factor: 3.105

3.  Mandibular osteoradionecrosis.

Authors:  William M Mendenhall
Journal:  J Clin Oncol       Date:  2004-11-01       Impact factor: 44.544

Review 4.  Osteoradionecrosis prevention myths.

Authors:  Michael J Wahl
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-03-01       Impact factor: 7.038

5.  Complete healing of severe osteoradionecrosis with treatment combining pentoxifylline, tocopherol and clodronate.

Authors:  S Delanian; J-L Lefaix
Journal:  Br J Radiol       Date:  2002-05       Impact factor: 3.039

6.  Pentoxifylline inhibits the proliferation of human fibroblasts derived from keloid, scleroderma and morphoea skin and their production of collagen, glycosaminoglycans and fibronectin.

Authors:  B Berman; M R Duncan
Journal:  Br J Dermatol       Date:  1990-09       Impact factor: 9.302

7.  Hyperbaric oxygen therapy for radionecrosis of the jaw: a randomized, placebo-controlled, double-blind trial from the ORN96 study group.

Authors:  Djillali Annane; Joël Depondt; Philippe Aubert; Maryvonne Villart; Pierre Géhanno; Philippe Gajdos; Sylvie Chevret
Journal:  J Clin Oncol       Date:  2004-11-01       Impact factor: 44.544

8.  Adverse radiation effects after radiosurgery may benefit from oral vitamin E and pentoxifylline therapy: a pilot study.

Authors:  Richard Williamson; Douglas Kondziolka; Hilal Kanaan; L Dade Lunsford; John C Flickinger
Journal:  Stereotact Funct Neurosurg       Date:  2008-10-16       Impact factor: 1.875

Review 9.  Current management for late normal tissue injury: radiation-induced fibrosis and necrosis.

Authors:  Sylvie Delanian; Jean-Louis Lefaix
Journal:  Semin Radiat Oncol       Date:  2007-04       Impact factor: 5.934

10.  Pentoxifylline inhibits TNF-alpha production from human alveolar macrophages.

Authors:  L J Marques; L Zheng; N Poulakis; J Guzman; U Costabel
Journal:  Am J Respir Crit Care Med       Date:  1999-02       Impact factor: 21.405

View more
  3 in total

1.  The effects of pentoxifylline adminstration on fracture healing in a postmenopausal osteoporotic rat model.

Authors:  Mohammad Mahdi Vashghani Farahani; Reza Ahadi; Mohammadamin Abdollahifar; Mohammad Bayat
Journal:  Lab Anim Res       Date:  2017-03-27

Review 2.  Postradiation Fractures after Combined Modality Treatment in Extremity Soft Tissue Sarcomas.

Authors:  Meredith K Bartelstein; Divya Yerramilli; Alexander B Christ; Shachar Kenan; Koichi Ogura; Tomohiro Fujiwara; Nicola Fabbri; John H Healey
Journal:  Sarcoma       Date:  2021-03-15

3.  Outcome of stereotactic body radiation for treatment of nasal and nasopharyngeal lymphoma in 32 cats.

Authors:  Alicja I Reczynska; Susan M LaRue; Mary-Keara Boss; Ber-In Lee; Del Leary; Kelsey Pohlmann; Lynn Griffin; Susan Lana; Tiffany Wormhoudt Martin
Journal:  J Vet Intern Med       Date:  2022-02-21       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.